- What Domain 1 Actually Covers
- Why Scientific Rationale Matters for a PI
- Core Concepts You Must Master
- Study Design Breakdown for the Exam
- Statistical Foundations Tested in Domain 1
- ICH E6(R3) and Its Impact on Domain 1
- How Domain 1 Questions Are Written
- Fitting Domain 1 Into Your Prep Schedule
- Frequently Asked Questions
- Domain 1 carries 15% of the 125-question ACRP-PI exam - roughly 19 scored questions you cannot afford to guess through.
- Questions test applied judgment on research design choices a PI makes, not textbook definitions alone.
- ICH E6(R3) becomes the governing GCP standard on July 15, 2026 - Domain 1 study materials must reflect this shift.
- Randomization, blinding, bias control, and protocol scientific rationale are the highest-yield subtopics in this domain.
What Domain 1 Actually Covers
Domain 1: Scientific Rationale and Principles of Research Design accounts for 15% of the Certified Principal Investigator (ACRP-PI) exam administered by the Association of Clinical Research Professionals. At 125 total questions across a 180-minute exam, that percentage translates to approximately 19 scored questions drawn from this content area - a meaningful block that rewards candidates who invest structured time here.
The domain is not about proving you can recite study design terminology. The exam tests whether you, as a practicing PI or Sub-I with at least 3,000 hours of essential PI activities (or 1,500 with a qualifying waiver), can apply design principles to real-world protocol decisions. The difference is significant when you sit down with a scenario-based multiple-choice question asking you to evaluate whether a proposed control arm is scientifically justified or whether a crossover design is appropriate given a drug's half-life.
For a broader look at how Domain 1 fits among all six exam areas, see the ACRP-PI Exam Domains 2026: Complete Guide to All 6 Content Areas, which maps weights, relationships, and recommended priority order across the full blueprint.
Why Scientific Rationale Matters for a PI
A principal investigator is not simply a recruiter or a data collector. The PI role carries accountability for the scientific integrity of research conducted at a site. That means a PI must be able to read a protocol's scientific rationale section critically, recognize when a design choice introduces avoidable bias, and articulate why the study population, endpoints, and comparators were selected.
Regulators and sponsors expect PIs to understand what they are running. IRBs ask about scientific merit. Auditors from regulatory authorities review whether the PI understood the protocol's design well enough to implement it faithfully. Domain 1 exists on the exam precisely because these competencies define competent PI practice.
Understanding the scientific underpinning of research design also feeds directly into Domain 2 (Ethical and Safety Considerations), which carries the highest exam weight at 22%. A poorly designed study - one that cannot answer its primary question - cannot be ethically justified. The risk-benefit calculation breaks down when the "benefit" side rests on a flawed design. Candidates who master Domain 1 thinking will find Domain 2 reasoning substantially easier.
Core Concepts You Must Master
The Research Question and Hypothesis Structure
Every clinical trial begins with a precisely framed research question. The exam tests whether candidates understand the components of a well-formed clinical hypothesis: the PICO framework (Population, Intervention, Comparator, Outcome) is foundational, but the exam pushes further into how hypothesis type - superiority, non-inferiority, equivalence - drives design, sample size, and statistical testing choices. A PI who cannot distinguish a non-inferiority trial margin from a superiority threshold will make critical protocol deviations without recognizing them as such.
High-Yield: Hypothesis Types and Design Implications
The exam frequently presents scenarios where you must identify the correct hypothesis type or flag a mismatch between hypothesis and design.
- Superiority trials: Designed to show the experimental treatment is better than control; two-sided testing is standard.
- Non-inferiority trials: Designed to show the experimental treatment is not worse than control by more than the pre-specified non-inferiority margin (delta); the margin must be scientifically and clinically justified in the protocol.
- Equivalence trials: Designed to show treatments perform within a symmetrical margin; requires larger sample sizes than superiority trials.
- PI responsibility: Understanding which type applies determines how the PI interprets interim results, handles early stopping considerations, and communicates findings to the IRB.
Control Groups and Comparators
Domain 1 dedicates substantial weight to the scientific justification for comparator selection. Active control, placebo control, historical control, and no-treatment control each carry different scientific and ethical implications. The ICH E10 guideline on choice of control group is a reference document worth reviewing - it frames how regulators evaluate whether a control arm selection is defensible. The exam will ask you to apply this reasoning, not merely recall the guideline's existence.
Bias: Identification and Control Mechanisms
Selection bias, performance bias, detection bias, attrition bias, and reporting bias are all testable. More importantly, the exam tests the mechanisms used to control them: randomization (and its variants - simple, block, stratified, adaptive), allocation concealment, blinding (single, double, triple, and when each is appropriate or impractical), and intention-to-treat versus per-protocol analysis approaches.
Key Takeaway
Allocation concealment and blinding are frequently confused on the exam. Allocation concealment prevents selection bias before randomization occurs. Blinding prevents performance and detection bias after randomization. A study can have one without the other - know when each applies and which bias each controls.
Study Design Breakdown for the Exam
| Design Type | Key Feature | Primary PI Accountability | Common Exam Angle |
|---|---|---|---|
| Parallel Group RCT | Each participant receives one treatment | Maintaining randomization integrity and blinding throughout | When to break blind; protocol deviation recognition |
| Crossover | Participants receive multiple treatments in sequence | Managing washout periods; carryover effect monitoring | Appropriate vs. inappropriate indications given half-life |
| Factorial | Tests two or more interventions simultaneously | Understanding interaction effects on endpoint interpretation | Identifying confounding from interaction terms |
| Adaptive | Pre-specified modifications allowed based on interim data | Maintaining operational blinding during adaptation | Distinguishing pre-specified from ad hoc modifications |
| Phase I-IV Distinctions | Different objectives, populations, sample sizes | Matching safety monitoring intensity to phase-appropriate risk | Correct phase for a described study objective |
Observational designs - cohort, case-control, and cross-sectional - also appear in Domain 1, particularly in questions about evidence hierarchy and what a PI must understand when a registry study or natural history study is conducted alongside an interventional trial.
Statistical Foundations Tested in Domain 1
The ACRP-PI exam is not a biostatistics certification, but Domain 1 requires statistical literacy at the level a PI needs to fulfill oversight responsibilities. You will not be asked to calculate a p-value, but you will be asked to interpret one in context. The on-screen calculator available during the exam supports straightforward arithmetic, not statistical computation - the questions are conceptual.
What Statistical Literacy Means for the PI Exam
- Sample size and power: Why underpowered studies are scientifically and ethically problematic; what drives sample size calculations (effect size, alpha, power, dropout rate).
- Primary vs. secondary endpoints: How multiplicity affects interpretation; why a study that "misses" its primary endpoint cannot be rescued by positive secondary endpoints without pre-specification.
- Type I and Type II errors: The consequences of each in a clinical trial context - approving an ineffective drug versus failing to approve an effective one.
- Interim analyses and stopping rules: Why unplanned interim analyses inflate Type I error; the role of Data Safety Monitoring Boards in protecting study integrity.
- Intention-to-treat principle: Why ITT analysis protects against bias introduced by dropout patterns; when modified ITT definitions are used and how they must be pre-specified.
ICH E6(R3) and Its Impact on Domain 1
Beginning July 15, 2026, ICH E6(R3) replaces ICH E6(R2) as the GCP standard referenced in the ACRP-PI exam. For Domain 1 specifically, this matters because E6(R3) introduces a more prominent risk-based framework that connects directly to study design decisions.
Under E6(R3), the concept of a risk-proportionate approach to trial oversight is embedded into how studies are designed, not just how they are monitored. The scientific rationale for a study must now more explicitly connect to a risk assessment framework. A PI sitting for the exam in 2026 or after must understand E6(R3)'s Annex 2 provisions for decentralized trial elements, since these alter how design decisions about data collection, visit structures, and endpoint verification are made and documented.
Candidates studying from older preparation materials should verify that their resources have been updated to E6(R3). The ACRP-PI Study Guide 2026: How to Pass on Your First Attempt addresses this resource-vetting process in detail and identifies which reference documents require updating before your exam date.
It is also worth noting that the ACRP-PI exam is an ICH-only exam - it is not country-specific. Domain 1 questions are framed against ICH guidelines (E6, E8, E9, E10), not FDA or EMA regulations specifically. Candidates accustomed to US-regulatory framing should practice repositioning their reasoning to the ICH framework.
How Domain 1 Questions Are Written
The ACRP-PI exam uses scenario-based multiple-choice questions. Domain 1 questions typically present a protocol description or a site scenario and ask the candidate to evaluate, select, or justify a design decision. Stems are often 80-120 words long, describing a specific trial context before posing the question.
Distractor answers in Domain 1 questions frequently include:
- A technically correct statement about research design that does not apply to the scenario described.
- A design choice that would be appropriate for a different hypothesis type than the one specified.
- An answer that confuses randomization with allocation concealment, or blinding with masking in a non-standard context.
- A statistically valid approach that violates the pre-specified statistical analysis plan.
The exam includes unscored pretest items distributed throughout the 125 questions. You cannot identify which questions are pretest items, so every Domain 1 question must be treated as scored. For more on navigating exam question structure and timing strategy, the ACRP-PI Exam Day Tips: 15 Strategies to Maximize Your Score article covers pacing approaches specific to the 180-minute format.
If you want to calibrate your current Domain 1 knowledge against realistic question stems before investing further study time, the ACRP-PI practice tests at principalexam.com include domain-specific question sets that mirror the applied scenario format of the actual exam.
Fitting Domain 1 Into Your Prep Schedule
Given Domain 1's 15% weight, it warrants approximately two focused weeks in a standard 10-12 week preparation plan - enough time to build conceptual fluency and apply it through practice questions, but not so much that higher-weighted domains suffer. The recommended sequencing is to study Domain 1 first, because its content provides the scientific scaffolding that makes Domain 2 (Ethical and Safety Considerations, 22%), Domain 4 (Clinical Trial Operations, 21%), and Domain 6 (Data Management, 13%) significantly more intuitive.
Foundation Building
- Review ICH E8(R1) - General Considerations for Clinical Studies; focus on the objectives hierarchy and quality factors
- Master hypothesis types (superiority, non-inferiority, equivalence) with clinical trial examples
- Study randomization and allocation concealment mechanisms; practice distinguishing them
- Review study design types (parallel, crossover, factorial, adaptive, Phase I-IV) using a comparison framework
- Complete 20-30 Domain 1 practice questions; review every incorrect answer against ICH E6(R3) rationale
Applied Integration
- Deep dive into bias types and the specific design features that control each
- Statistical literacy: Type I/II errors, power, sample size rationale, ITT vs. per-protocol
- Review ICH E10 (Choice of Control) and connect control arm justification to IRB scientific review
- Complete a full timed practice block mixing Domain 1 questions with Domain 2 questions to build cross-domain reasoning
- Revisit any subtopics where practice question accuracy falls below your target threshold
Candidates who want a comprehensive look at how Domain 1 week-by-week planning connects to the full 10-week schedule should visit the ACRP-PI Study Guide 2026: How to Pass on Your First Attempt. For candidates evaluating whether the certification investment is worthwhile before committing to an exam prep schedule, Is the ACRP-PI Certification Worth It? Complete ROI Analysis 2026 provides a thorough career impact analysis.
A note on exam registration: the ACRP-PI exam fee for members is $435 at early-bird pricing or $460 at regular pricing; non-members pay $485 (early-bird) or $600 (regular). The exam is delivered at PSI in-person test centers or via live remote proctoring. Full fee structure details and registration mechanics are covered in the ACRP-PI Certification Cost 2026: Complete Pricing Breakdown. Planning your study schedule to align with an early-bird registration deadline is worth the effort given the savings available to members.
For a connected look at Domain 1's neighboring content areas, the domain-specific guides for ACRP-PI Domain 2: Ethical and Safety Considerations (22%) - Complete Study Guide 2026 and ACRP-PI Domain 4: Clinical Trial Operations (21%) - Complete Study Guide 2026 show how Domain 1 concepts extend into the highest-weighted areas of the exam. Practicing across these domains together in your second study week will strengthen your ability to handle scenario questions that draw on multiple content areas simultaneously - which is precisely how the exam is constructed.
The ACRP-PI practice test platform at principalexam.com allows you to filter questions by domain, making it straightforward to run targeted Domain 1 practice sessions in Week 1 and then shift to mixed-domain simulation in Week 2.
Frequently Asked Questions
Domain 1 accounts for 15% of the 125-question exam, which equates to approximately 19 questions. Some of these may be unscored pretest items, but you have no way of knowing which ones - treat every Domain 1 question as scored and prepare accordingly.
No. The exam tests statistical literacy and conceptual understanding, not formula computation. You need to understand what drives sample size calculations, what Type I and Type II errors mean in a clinical trial context, and how statistical analysis plans protect study integrity - but you will not calculate a chi-square or power estimate. An on-screen calculator is provided for basic arithmetic.
ICH E6(R3), effective July 15, 2026, formalizes a risk-proportionate approach that connects to how study designs are structured and justified - not just monitored. Annex 2 covers decentralized trial elements that affect design decisions. Candidates testing in 2026 or later should ensure their study materials reference E6(R3), not E6(R2). The scientific rationale section of protocols must now align with the risk framework E6(R3) establishes.
Experienced PIs often find the applied aspects of Domain 1 intuitive because they have read and implemented protocols. The challenge is translating practical experience into exam-style reasoning that references ICH frameworks explicitly. PIs who have managed mostly one design type may find questions about crossover, factorial, or adaptive designs less familiar. Practice questions that span design types are the most efficient preparation tool.
ICH E6(R3) (Good Clinical Practice), ICH E8(R1) (General Considerations for Clinical Studies), and ICH E10 (Choice of Control Group) are the highest-priority references for Domain 1. ICH E9 (Statistical Principles for Clinical Trials) supports the statistical literacy subtopics. Because the exam is ICH-only and not country-specific, prioritize ICH documents over FDA guidance documents when the two differ.
Ready to Start Practicing?
Test your Domain 1 knowledge right now with scenario-based practice questions built to mirror the actual ACRP-PI exam format. Filter by domain, track your weak spots, and build the applied reasoning skills the exam requires - all before registration day.
Start Free Practice Test- ACRP-PI Study Guide 2026: How to Pass on Your First Attempt
- ACRP-PI Domain 2: Ethical and Safety Considerations (22%) - Complete Study Guide 2026
- ACRP-PI Domain 3: Product Development and Regulation (12%) - Complete Study Guide 2026
- ACRP-PI Domain 4: Clinical Trial Operations (21%) - Complete Study Guide 2026